Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000182

Chairperson & CEO sold 1,960 shares at an average $597.76 ($1,171,609)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-05 Sale : show line 1 in the form 10b5-1 −200 $593.14 $118,628 326,203 I
2026-11-05 Sale : show line 2 in the form 10b5-1 −280 $594.51 $166,464 325,923 I
2026-11-05 Sale : show line 3 in the form 10b5-1 −120 $595.43 $71,452 325,803 I
2026-11-05 Sale : show line 4 in the form 10b5-1 −306 $596.71 $182,593 325,497 I
2026-11-05 Sale : show line 5 in the form 10b5-1 −237 $597.74 $141,665 325,260 I
2026-11-05 Sale : show line 6 in the form 10b5-1 −167 $598.74 $99,989 325,093 I
2026-11-05 Sale : show line 7 in the form 10b5-1 −10 $599.80 $5,998 325,083 I
2026-11-05 Sale : show line 8 in the form 10b5-1 −560 $601.11 $336,620 324,523 I
2026-11-05 Sale : show line 9 in the form 10b5-1 −80 $602.49 $48,199 324,443 I
Open-market sales · 1,960 sh · avg $597.76 · $1,171,609
Loading xslF345X06/primarydocument.xml…